Talphera to Host Second Quarter Financial Results and Corporate Update Call and Webcast on Thursday, August 14, 2025
Talphera (Nasdaq: TLPH), a specialty pharmaceutical company, will release its Q2 2025 financial results on Thursday, August 14, 2025 after market close. The company will host a conference call and webcast at 4:30 PM ET/1:30 PM PT to discuss the results and provide a business update.
Investors can access the webcast through Talphera's website investor section, which will include a slide presentation. A replay will be available for 90 days. For those joining by phone, North American callers can dial 1-800-836-8184, while international callers should use 1-646-357-8785 with conference ID 32530.
[]Talphera (Nasdaq: TLPH), un'azienda farmaceutica specializzata, pubblicher脿 i suoi risultati finanziari del secondo trimestre 2025 驳颈辞惫别诲矛 14 agosto 2025 dopo la chiusura dei mercati. La societ脿 terr脿 una conference call e una webcast alle 16:30 ET/13:30 PT per discutere i risultati e fornire un aggiornamento aziendale.
Gli investitori potranno accedere alla webcast tramite la sezione investitori del sito web di Talphera, che includer脿 anche una presentazione con slide. La registrazione sar脿 disponibile per 90 giorni. Per chi partecipa telefonicamente, i chiamanti dal Nord America possono comporre il numero 1-800-836-8184, mentre i chiamanti internazionali dovranno utilizzare il numero 1-646-357-8785 con ID conferenza 32530.
Talphera (Nasdaq: TLPH), una empresa farmac茅utica especializada, publicar谩 sus resultados financieros del segundo trimestre de 2025 el jueves 14 de agosto de 2025 despu茅s del cierre del mercado. La compa帽铆a realizar谩 una llamada conferencia y una transmisi贸n en vivo a las 4:30 PM ET/1:30 PM PT para discutir los resultados y ofrecer una actualizaci贸n empresarial.
Los inversores podr谩n acceder a la transmisi贸n en vivo a trav茅s de la secci贸n de inversores del sitio web de Talphera, que incluir谩 una presentaci贸n con diapositivas. La repetici贸n estar谩 disponible durante 90 d铆as. Para quienes se unan por tel茅fono, los llamantes de Norteam茅rica pueden marcar el 1-800-836-8184, mientras que los llamantes internacionales deben usar el 1-646-357-8785 con ID de conferencia 32530.
Talphera (雮橃姢雼�: TLPH)電� 鞝勲 鞝滌暯 須岇偓搿滌劀 2025雲� 2攵勱赴 鞛 鞁れ爜鞚� 2025雲� 8鞗� 14鞚� 氇╈殧鞚� 鞛� 毵堦皭 頉� 氚滍憸頃� 鞓堨爼鞛呺媹雼�. 須岇偓電� 霃欕秬 鞁滉皠 鞓ろ泟 4鞁� 30攵�/韮滍弶鞏� 鞁滉皠 鞓ろ泟 1鞁� 30攵�鞐� 旎嵓霟办姢 旖滉臣 鞗轨簮鞀ろ姼毳� 臧滌禍頃橃棳 鞁れ爜鞚� 雲检潣頃橁碃 靷梾 順勴櫓鞚� 鞐呺嵃鞚错姼頃� 瓴冹瀰雼堧嫟.
韴瀽鞛愲摛鞚� Talphera 鞗轨偓鞚错姼 韴瀽鞛� 靹轨厴鞚� 韱淀暣 鞗轨簮鞀ろ姼鞐� 鞝戩啀頃� 靾� 鞛堨溂氅�, 鞀澕鞚措摐 頂勲爤鞝犿厡鞚挫厴霃� 韽暔霅╇媹雼�. 鞛癌靻§潃 90鞚缄皠 鞝滉车霅╇媹雼�. 鞝勴檾 彀胳棳 鞁� 攵侂 歆�鞐� 鞝勴檾氩堩樃電� 1-800-836-8184鞚措┌, 甑牅 鞝勴檾電� 1-646-357-8785毳� 靷毄頃橁碃 旎嵓霟办姢 ID 32530毳� 鞛呺牓頃橂┐ 霅╇媹雼�.
Talphera (Nasdaq : TLPH), une soci茅t茅 pharmaceutique sp茅cialis茅e, publiera ses r茅sultats financiers du deuxi猫me trimestre 2025 le jeudi 14 ao没t 2025 apr猫s la cl么ture des march茅s. La soci茅t茅 organisera une conf茅rence t茅l茅phonique et un webcast 脿 16h30 ET / 13h30 PT pour discuter des r茅sultats et fournir une mise 脿 jour commerciale.
Les investisseurs pourront acc茅der au webcast via la section investisseurs du site web de Talphera, qui comprendra une pr茅sentation en diapositives. Une rediffusion sera disponible pendant 90 jours. Pour ceux qui participent par t茅l茅phone, les appelants nord-am茅ricains peuvent composer le 1-800-836-8184, tandis que les appelants internationaux doivent utiliser le 1-646-357-8785 avec l鈥檌dentifiant de conf茅rence 32530.
Talphera (Nasdaq: TLPH), ein spezialisiertes Pharmaunternehmen, wird seine Finanzergebnisse f眉r das zweite Quartal 2025 am Donnerstag, den 14. August 2025 nach B枚rsenschluss ver枚ffentlichen. Das Unternehmen wird um 16:30 Uhr ET/13:30 Uhr PT eine Telefonkonferenz und ein Webcast veranstalten, um die Ergebnisse zu besprechen und ein Unternehmensupdate zu geben.
Investoren k枚nnen 眉ber den Investor-Bereich auf der Talphera-Website auf das Webcast zugreifen, welches eine Pr盲sentation mit Folien enthalten wird. Eine Aufzeichnung wird f眉r 90 Tage verf眉gbar sein. F眉r Telefonteilnehmer aus Nordamerika steht die Nummer 1-800-836-8184 zur Verf眉gung, internationale Anrufer w盲hlen bitte 1-646-357-8785 mit der Konferenz-ID 32530.
- None.
- None.
Webcast Information
The webcast can be accessed 聽or by visiting the Investors section of the Company's website at www.talphera.com and clicking on the webcast link posted within Investors/News & Events/Upcoming Events section. The webcast will include a slide presentation and a replay will be available on the Talphera website for 90 days following the event.
Conference Call Information
Investors who wish to participate in the conference call may do so by dialing 1-800-836-8184 for North American callers, or 1-646-357-8785 (toll applies) for international callers outside of
About Talphera, Inc.
Talphera, Inc.聽is a specialty pharmaceutical company focused on the development and commercialization of innovative therapies for use in medically supervised settings. Talphera's lead product candidate, Niyad鈩� is a lyophilized formulation of nafamostat and is currently being studied under an investigational device exemption (IDE) as an anticoagulant for the extracorporeal circuit, and has received Breakthrough Device Designation status from the聽U.S. Food and Drug Administration聽(FDA).
This release is intended for investors only. For additional information about Talphera, please visit聽www.talphera.com.
View original content to download multimedia:
SOURCE Talphera, Inc.
FAQ
When will Talphera (TLPH) report Q2 2025 earnings?
How can investors access Talphera's Q2 2025 earnings call?
Where can I find Talphera's Q2 2025 earnings presentation slides?
How long will Talphera's Q2 2025 earnings call replay be available?
